1. Home
  2. CDT vs FAMI Comparison

CDT vs FAMI Comparison

Compare CDT & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • FAMI
  • Stock Information
  • Founded
  • CDT 2019
  • FAMI 2015
  • Country
  • CDT United States
  • FAMI China
  • Employees
  • CDT N/A
  • FAMI N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • FAMI Packaged Foods
  • Sector
  • CDT Health Care
  • FAMI Consumer Staples
  • Exchange
  • CDT Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • CDT 2.2M
  • FAMI 2.2M
  • IPO Year
  • CDT N/A
  • FAMI 2018
  • Fundamental
  • Price
  • CDT $2.80
  • FAMI $1.83
  • Analyst Decision
  • CDT
  • FAMI
  • Analyst Count
  • CDT 0
  • FAMI 0
  • Target Price
  • CDT N/A
  • FAMI N/A
  • AVG Volume (30 Days)
  • CDT 618.7K
  • FAMI 22.1K
  • Earning Date
  • CDT 08-11-2025
  • FAMI 08-08-2025
  • Dividend Yield
  • CDT N/A
  • FAMI N/A
  • EPS Growth
  • CDT N/A
  • FAMI N/A
  • EPS
  • CDT N/A
  • FAMI N/A
  • Revenue
  • CDT N/A
  • FAMI $64,131,332.00
  • Revenue This Year
  • CDT N/A
  • FAMI N/A
  • Revenue Next Year
  • CDT N/A
  • FAMI N/A
  • P/E Ratio
  • CDT N/A
  • FAMI N/A
  • Revenue Growth
  • CDT N/A
  • FAMI N/A
  • 52 Week Low
  • CDT $2.21
  • FAMI $1.43
  • 52 Week High
  • CDT $1,515.00
  • FAMI $7.92
  • Technical
  • Relative Strength Index (RSI)
  • CDT 38.74
  • FAMI 50.96
  • Support Level
  • CDT $2.57
  • FAMI $1.65
  • Resistance Level
  • CDT $3.05
  • FAMI $2.00
  • Average True Range (ATR)
  • CDT 0.23
  • FAMI 0.13
  • MACD
  • CDT 0.26
  • FAMI -0.01
  • Stochastic Oscillator
  • CDT 70.24
  • FAMI 51.43

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: